Results
|
|
1901.
|
|
|
|
1902.
|
|
|
|
1903.
|
|
|
|
1904.
|
|
|
|
1905.
|
|
|
|
1906.
|
|
|
|
1907.
|
Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression. [electronic resource] by
- Ban, Jung Ok
- Oh, Ju Hoon
- Son, Seung Mo
- Won, Dohee
- Song, Ho Seub
- Han, Sang Bae
- Moon, Dong Cheul
- Kang, Keon Wook
- Song, Min Jong
- Hong, Jin Tae
Producer: 20120125
In:
Cancer biology & therapy vol. 12
Availability: No items available.
|
|
|
1908.
|
N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase. [electronic resource] by
- Akiba, Jun
- Murakami, Yuichi
- Noda, Masaki
- Watari, Kosuke
- Ogasawara, Sachiko
- Yoshida, Takafumi
- Kawahara, Akihiko
- Sanada, Sakiko
- Yasumoto, Makiko
- Yamaguchi, Rin
- Kage, Masayoshi
- Kuwano, Michihiko
- Ono, Mayumi
- Yano, Hirohisa
Producer: 20111025
In:
Cancer letters vol. 310
Availability: No items available.
|
|
|
1909.
|
B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. [electronic resource] by
- Serriari, Nacer-Eddine
- Gondois-Rey, Françoise
- Guillaume, Yves
- Remmerswaal, Ester B M
- Pastor, Sonia
- Messal, Nassima
- Truneh, Alemseged
- Hirsch, Ivan
- van Lier, René A W
- Olive, Daniel
Producer: 20101123
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 185
Availability: No items available.
|
|
|
1910.
|
|
|
|
1911.
|
|
|
|
1912.
|
|
|
|
1913.
|
In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition. [electronic resource] by
- Balachandran, C
- Emi, N
- Arun, Y
- Yamamoto, N
- Duraipandiyan, V
- Inaguma, Yoko
- Okamoto, Akinao
- Ignacimuthu, S
- Al-Dhabi, N A
- Perumal, P T
Producer: 20160801
In:
Chemico-biological interactions vol. 249
Availability: No items available.
|
|
|
1914.
|
CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer. [electronic resource] by
- Zhang, Kai
- Hong, Ruoxi
- Kaping, Lee
- Xu, Fei
- Xia, Wen
- Qin, Ge
- Zheng, Qiufan
- Lu, Qianyi
- Zhai, Qinglian
- Shi, Yanxia
- Yuan, Zhongyu
- Deng, Wuguo
- Chen, Miao
- Wang, Shusen
Producer: 20191213
In:
Cancer letters vol. 447
Availability: No items available.
|
|
|
1915.
|
|
|
|
1916.
|
|
|
|
1917.
|
|
|
|
1918.
|
|
|
|
1919.
|
|
|
|
1920.
|
|